Trial intelligence / Profile preview

Statin Therapy and Lifestyle Modification for Atherosclerosis in Cancer Survivors

NCT02114697Phase 4Terminated

Sponsor
Emory University
Start
Apr 2014
Primary completion
Jul 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in atherosclerosis, sponsored by Emory University. Started Apr 2014; status: terminated.

02

Drugs

rosuvastatin
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT02114697.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02114697.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call